Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.73%572.402.7%$664.87m
AMGNAmgen, Inc. -0.92%228.971.3%$587.18m
ILMNIllumina, Inc. -0.81%317.853.5%$555.47m
GILDGilead Sciences, Inc. -0.56%60.211.0%$501.35m
VRTXVertex Pharmaceuticals, Inc. -1.47%211.381.9%$488.35m
ARRYArray BioPharma Inc. 2.18%39.3414.2%$478.36m
MRNAModerna, Inc. -4.12%68.370.0%$471.73m
IMMUImmunomedics, Inc. 0.11%87.8211.0%$373.27m
NVAXNovavax, Inc. -7.32%91.1696.5%$302.79m
ALXNAlexion Pharmaceuticals, Inc. -4.69%118.192.0%$280.41m
BIIBBiogen, Inc. 0.67%268.911.6%$264.60m
EXASEXACT Sciences Corp. -3.31%99.6120.7%$219.55m
BNTXBioNTech SE -7.03%87.720.0%$214.67m
SRNESorrento Therapeutics, Inc. -4.50%7.851.4%$181.33m
SGENSeagen Inc. -0.16%197.716.0%$162.37m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.